A new hope for stroke? Evidence for the use of rDSPAα1 (desmoteplase) in acute ischemic stroke

Proceedings of the Western Pharmacology Society

Volumn 49, Issue , 2006, Pages 1-5

  Pugsley, Michael K ^a   Lipka, Leslie ^a   Petersen, Karl Uwe ^b   Soehngen, Mariola ^b  

^a FOREST RESEARCH INSTITUTE   (United States)

^b PAION Deutschland GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; AMYLOID BETA PROTEIN; DESMOTEPLASE; FIBRIN; FIBRINOGEN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; PLASMINOGEN ACTIVATOR; PRION PROTEIN; SERINE PROTEINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORPUS STRIATUM; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; HUMAN; IN VIVO STUDY; KRINGLE DOMAIN; NEUROTOXICITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 34247518320     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Bonita, R. (1992) Lancet 339(8789), 342-344.
2. Marler, J.R. and Goldstein, L.B. (2003) Science 301(5640), 1677.
3. Katzan, I.L., Furlan, A.J., Lloyd, L.E., Frank, J.I., Harper, D.L., Hinchey, J.A., Hammel, J.P., Qu, A., and Sila, C.A. (2000) JAMA 283(9), 1151-1158.
4. Nilasena, D.S., Kresowik, T.F., Wiblin, R.T., Piskac, A.F., Kresowik, R.A., Brenton, M.A., Wilwert, J.M., and Hendel, M.E. (2002) Stroke 33, 354.
5. Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S.E., Morgenstern, L.B., Bratina, P.L., Yatsu, F.M., and Grotta, J.C. (1998) Stroke 29(1), 18-22.
6. Schleuning, W.D., Alagon, A., Boidol, W., Bringmann, P., Petri, T., Kratzschmar, J., Haendler, B., Langer, G., Baldus, B., Witt, W., and et al. (1992) Ann N Y Acad Sci 667, 395-403.
7. Bringmann, P., Gruber, D., Liese, A., Toschi, L., Kratzchmar, J., Schleuning, W.D., and Donner, P. (1995) J Biol Chem 270(43), 25596-25603.
8. Stewart, R.J., Fredenburgh, J.C., and Weitz, J.I. (1998) J Biol Chem 273(29), 18292-18299.
9. Kruithof, E.K. and Schleuning, W.D. (2004) Thromb Haemost 92(3), 559-567.
10. Epple, G., Schleuning, W.D., Kettelgerdes, G., Kottgen, E., Gessner, R., and Praus, M. (2004) J Thromb Haemost 2(6), 962-968.
11. Witt, W., Maass, B., Baldus, B., Hildebrand, M., Donner, P., and Schleuning, W.D. (1994) Circulation 90(1), 421-426.
12. Shuaib, A., Comparing the therapeutic benefit of desmoteplase, reteplase, and alteplase in a rat model of embolic middle cerebral artery (MCA) occlusion. 2001, PAION AG: Aachen. Data presented at: International Stroke Conference; February 16, 2006; Kissimmee, FL.
13. Liberatore, G.T., Samson, A., Bladin, C., Schleuning, W.D., and Medcalf, R.L. (2003) Stroke 34(2), 537-543.
14. Reddrop, C., Moldrich, R.X., Beart, P.M., Farso, M., Liberatore, G.T., Howells, D.W., Petersen, K.U., Schleuning, W.D., and Medcalf, R.L. (2005) Stroke 36(6), 1241-1246.
15. Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K.R., Soehngen, M., and Warach, S. (2005) Stroke 36(1), 66-73.
16. Furlan, A.J., Eyding, D., Albers, G.W., Al-Rawi, Y., Lees, K.R., Rowley, H.A., Sachara, C., Soehngen, M., Warach, S., and Hacke, W. (2006) Stroke 37(5), 1227-1231.
17. Pugsley, M.K., Petersen, K.-U., Gupta, S., and Eyding, D. (2006) Stroke 37(2), 656.